On Wednesday, Endologix, Inc. (NASDAQ:ELGX)’s shares inclined 3.20% to $12.26.
Endologix, Inc. (ELGX), developer and marketer of innovative treatments for aortic disorders, declared that it has designated Vaseem Mahboob to the position of Chief Financial Officer, effective October 15, 2015. Mr. Mahboob succeeds Shelley Thunen, who is resigning as part of the Company’s formerly declared CFO transition.
Endologix, Inc. develops, manufactures, markets, and sells medical devices for the treatment of abdominal aortic aneurysms in the United States and internationally. The company offers minimally-invasive endovascular repair (EVAR) products, counting EVAR stent graft and catheter delivery system under the brand names Powerlink, IntuiTrak, AFX, and VELA Proximal Endograft.
At the end of Wednesday’s trade, Goldman Sachs Group Inc (NYSE:GS)‘s shares surged 0.96% to $173.51.
Goldman Sachs Asset Administration declared the launch of its first exchange-traded fund, the ActiveBeta® US Large Cap Equity ETF (GSLC).The fund is the first in a series of ETFs that will track GSAM’s proprietary ActiveBeta® index.
“We are excited to enter the ETF market,” said Tim O’Neill, Global Co-Head of the Investment Administration Division, which comprises GSAM. “Our approach to ETFs continues our legacy of investment innovation and at a cost that makes them accessible to all investors.”
The ActiveBeta® US Large Cap Equity ETF (GSLC) shares many of the same benefits of traditional ETFs—a defined strategy, diversified exposure to stocks and low costs—but it is powered by the Goldman Sachs ActiveBeta® index, a performance-seeking methodology from Goldman Sachs that delivers the potential to outperform the market.
The Goldman Sachs Group, Inc. operates as an investment banking, securities, and investment administration company worldwide. The company operates through four segments: Investment Banking, Institutional Client Services, Investing & Lending, and Investment Administration.
Chimera Investment Corporation (NYSE:CIM), ended its Wednesday’s trading session with 1.21% gain, and closed at $13.37.
Chimera Investment Corporation (CIM) declared that its Board of Directors has set the date for the Company’s Annual Meeting of Stockholders in addition to the record date for stockholders eligible to vote at the meeting.
The Annual Meeting will be held on Thursday, December 10, 2015. Stockholders of record as of the close of business on October 21, 2015 will be eligible to vote at the meeting.
Chimera Investment Corporation operates as a real estate investment trust in the United States. The company, through its auxiliaries, invests in residential mortgage-backed securities (RMBS), residential mortgage loans, commercial mortgage loans, real estate-related securities, and various other asset classes.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
